“Designing treatments unique to individual patients has always been the promised goal of personalized medicine. After 25 ...

In this episode of the Applied Clinical Trials Podcast, C.K. Wang, MD, chief medical officer at COTA; and Sujay Jadhav, CEO ...

In today’s ACT Brief, we explore how Bayesian trial designs are gaining traction in rare disease research, what priorities ...

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

In today’s ACT Brief, we explore how sites are taking the lead on AI adoption to strengthen feasibility and enrollment, why ...

Jonathan Andrus, co-CEO of CRIO, discusses how governance across the data lifecycle, site-focused technology adoption, and ...

Enhance predictability and quality in design, planning and trial delivery by leveraging novel tools and approaches ...

At SCOPE Summit 2026, site leaders shared how AI is transforming feasibility, patient identification, and enrollment ...

Andrus: Collaboration really needs to start earlier—during protocol development, not after the fact. Clinical operations, ...

In a new FAQ article on ACT, evolving outsourcing strategies reflect growing demand for flexibility as trial complexity ...

As clinical development grows more complex, sponsors are rethinking how outsourcing models, technology, and partnerships ...